Invention Application
- Patent Title: COMBINATION FORMULATIONS OF TAXANES AND MTOR INHIBITORS
-
Application No.: PCT/US2019/065440Application Date: 2019-12-10
-
Publication No.: WO2020123481A1Publication Date: 2020-06-18
- Inventor: HUMPHREYS, Robin , TARDI, Paul , WAN, Leon , LIBOIRON, Barry
- Applicant: CELATOR PHARMACEUTICALS INC.
- Applicant Address: 200 PrincetonSouth Corporate Center Suite 180 Ewing, New Jersey 08628 US
- Assignee: CELATOR PHARMACEUTICALS INC.
- Current Assignee: CELATOR PHARMACEUTICALS INC.
- Current Assignee Address: 200 PrincetonSouth Corporate Center Suite 180 Ewing, New Jersey 08628 US
- Agency: MURASHIGE, Kate H. et al.
- Priority: US62/777,704 20181210
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/14 ; A61K9/51 ; A61K31/337 ; A61K47/34
Abstract:
The invention relates to compositions and methods for improved delivery of combinations of therapeutic agents. More particularly, the invention concerns delivery systems which provide combinations of taxanes and mTOR inhibitors and derivatives thereof as well as methods of treating cancer using the same.
Information query
